We read the article entitled "Association between g-glutamyltransferase level and cardiovascular or all-cause mortality in patients with coronary artery disease: a systematic review and meta-analysis" 1 with great interest. The authors performed this meta-analysis to evaluate the prognostic significance of g-glutamyltransferase (GGT) levels for cardiovascular (CV) and allcause mortality in patients with coronary artery disease (CAD).
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This meta-analysis 1 provides evidence that high serum GGT level is probably an independent predictor of CV and all-cause mortality in patients with CAD. The patients with the highest GGT level exhibited approximately 1.5-and 2-fold higher risk of CV and all-cause mortality, respectively. 1 Four isoforms of GGT have been found in the platelets and neutrophils. 2, 3 It is known that GGT converts leukotriene C4 to leukotriene D4 in the platelet cell membrane, and these products are also prothrombotic. 3 The concentration of GGT in the platelet membrane may reflect the level of platelet activation. 4 Demirtaş et al investigate the predictive value of platelet membrane GGT activity for the development of major adverse cardiac events (MACEs; recurrent angina pectoris, myocardial infarction, rehospitalization due to acute coronary syndrome [ACS], and death) after a 3-month follow-up (MACE-3 M) in patients hospitalized with ACS. 5 In their study, serum GGT levels had no differences between MACE þ and MACE À groups, but platelet GGT was significantly higher in MACE þ group. Also, platelet GGT-specific activity was found to be an independent predictor of MACE and a stronger prognostic marker than serum GGT activity. According to these findings, subtypes of GGT could contribute to the relation between GGT and end points of CAD.
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